-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Immunocore Holdings plc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2023 to Q1 2025.
- Immunocore Holdings plc Operating Income (Loss) for the quarter ending March 31, 2025 was -$3.62M, a 86.4% increase year-over-year.
- Immunocore Holdings plc Operating Income (Loss) for the twelve months ending March 31, 2025 was -$47.6M, a 33.4% increase year-over-year.
- Immunocore Holdings plc annual Operating Income (Loss) for 2024 was -$70.5M, a 18.1% decline from 2023.
- Immunocore Holdings plc annual Operating Income (Loss) for 2023 was -$59.6M, a 15.4% decline from 2022.
- Immunocore Holdings plc annual Operating Income (Loss) for 2022 was -$51.7M, a 70.4% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)